TC
THTX

Truvestments Capital’s Theratechnologies THTX Stock Holding History

Truvestments Capital’s Portfolio THTX Stock Details THTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-298
Closed -$703 – 1118
2025
Q2 		$703 Hold
298
– – ﹤0.01% 891
2025
Q1 		$417 Hold
298
– – ﹤0.01% 967
2024
Q4 		$539 Hold
298
– – ﹤0.01% 949
2024
Q3 		$370 Buy
+298
New +$404 ﹤0.01% 883
2024
Q2 		– Sell
-298
Closed -$495 – 644
2024
Q1 		$495 Hold
298
– – ﹤0.01% 673
2023
Q4 		$483 Hold
298
– – ﹤0.01% 738
2023
Q3 		$641 Buy
+298
New +$638 ﹤0.01% 641

Other funds holding THTX

JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CWP
Cyndeo Wealth Partners St. Petersburg, Florida $2.12B AUM 24.61% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
GIP
Greatmark Investment Partners Columbus, Georgia $906M AUM 16.08% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $5.64B AUM

Truvestments Capital's THTX Position: Q3 2025 in Review

Truvestments Capital sold out of Theratechnologies (THTX) in Q3 2025, closing a stake of 298 shares — an estimated $703 sold.

Truvestments Capital first reported a position in THTX in Q3 2023 and held it in 7 quarters. The position peaked at $703 in Q2 2025. 10 funds tracked by Wall St. Rank hold THTX as of Q3 2025.

  • Truvestments Capital reported no remaining Theratechnologies position as of Q3 2025 after selling out during the quarter.
  • Truvestments Capital sold 298 Theratechnologies shares in Q3 2025, an estimated $703.
  • Truvestments Capital first reported a position in Theratechnologies in Q3 2023 and held it in 7 quarters.
  • Truvestments Capital's Theratechnologies position peaked at $703 in Q2 2025.
  • 10 funds tracked by Wall St. Rank held Theratechnologies as of Q3 2025.

Based on Truvestments Capital's 13F filing for Q3 2025, filed 14 Nov 2025.